文献速递心血管MR

主动脉瓣狭窄患者心脏磁共振晚期钆增强的患病率及预后价值:荟萃分析

Prevalence and prognostic value of late gadolinium enhancement on CMR in aortic stenosis: meta-analysis.
PubMed 文献 · Eur Radiol · 2019-08-12

该系统检索共纳入19项观察性队列研究、2032例主动脉瓣狭窄患者,平均年龄69.8岁、平均随访2.8年;晚期钆增强患病率为49.6%,非梗死型占63.6%,局灶性纤维化范围占左心室质量的3.83%(95%CI 2.14–5.52)。晚期钆增强与全因死亡(合并OR 3.26,95%CI 1.72–6.18)和心血管死亡(合并OR 2.89,95%CI 1.90–4.38)风险升高相关。

要点

  • 主动脉瓣狭窄患者中约半数(49.6%)存在晚期钆增强所示局灶性心肌纤维化。
  • 检出的局灶性纤维化以非梗死型为主(63.6%)。
  • 晚期钆增强存在与全因死亡和心血管死亡风险升高相关。

核心结论

  • 晚期钆增强在主动脉瓣狭窄患者中患病率高,对全因死亡和心血管死亡有预测价值,提示其可能用于风险分层。

研究设计与样本

  • 系统检索PubMed和EMBASE,纳入分析晚期钆增强患病率及其与临床结局关系的观察性队列研究,共19项研究、2032例患者,平均年龄69.8岁,平均随访2.8年。

关键影像表现/征象

  • 晚期钆增强在主动脉瓣狭窄患者中的患病率为49.6%,其中非梗死型占63.6%。
  • 局灶性纤维化范围以占左心室质量的百分比表示为3.83%(95%CI 2.14–5.52,p<0.0001)。

诊断标准与关键数值

  • 晚期钆增强存在与全因死亡风险升高相关,合并OR为3.26(95%CI 1.72–6.18,p=0.0003)。
  • 晚期钆增强存在与心血管死亡风险升高相关,合并OR为2.89(95%CI 1.90–4.38,p<0.0001)。

临床应用与阅片要点

  • 原文结论提示晚期钆增强可能在主动脉瓣狭窄患者风险分层中发挥作用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The aim of this study was to investigate the prevalence and prognostic value of late gadolinium enhancement (LGE), as assessed by cardiovascular magnetic resonance (CMR) imaging, in patients with aortic stenosis.

METHODS AND RESULTS: A systematic search of PubMed and EMBASE was performed, and observational cohort studies that analysed the prevalence of LGE and its relation to clinical outcomes in patients with aortic stenosis were included. Odds ratios were used to measure an effect of the presence of LGE on both all-cause and cardiovascular mortality. Nineteen studies were retrieved, accounting for 2032 patients (mean age 69.8 years, mean follow-up 2.8 years). We found that LGE is highly prevalent in aortic stenosis, affecting half of all patients (49.6%), with a non-infarct pattern being the most frequent type (63.6%). The estimated extent of focal fibrosis, expressed in % of LV mass, was equal to 3.83 (95% CI [2.14, 5.52], p < 0.0001). The meta-analysis showed that the presence of LGE was associated with increased all-cause (pooled OR [95% CI] = 3.26 [1.72, 6.18], p = 0.0003) and cardiovascular mortality (pooled OR [95% CI] = 2.89 [1.90, 4.38], p < 0.0001).

CONCLUSIONS: LGE by CMR is highly prevalent in aortic stenosis patients and exhibits a substantial value in all-cause and cardiovascular mortality prediction. These results suggest a potential role of LGE in aortic stenosis patient risk stratification.

KEY POINTS: • Up to the half of aortic stenosis patients are affected by myocardial focal fibrosis. • Sixty-four percent of focal fibrosis detected by LGE-CMR is non-infarct type. • The presence of focal fibrosis triples all-cause and cardiovascular mortality.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Balciunaite G, Skorniakov V, Rimkus A, et al. Prevalence and prognostic value of late gadolinium enhancement on CMR in aortic stenosis: meta-analysis. Eur Radiol. 2019. PMID: 31407030. doi:10.1007/s00330-019-06386-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。